现代高通量测序在侵入性产前诊断中的机遇和局限性。

IF 1.9 4区 医学 Q2 OBSTETRICS & GYNECOLOGY
Geburtshilfe Und Frauenheilkunde Pub Date : 2025-07-11 eCollection Date: 2025-09-01 DOI:10.1055/a-2567-3396
Heinz Gabriel, Markus Stumm
{"title":"现代高通量测序在侵入性产前诊断中的机遇和局限性。","authors":"Heinz Gabriel, Markus Stumm","doi":"10.1055/a-2567-3396","DOIUrl":null,"url":null,"abstract":"<p><p>Prenatal diagnostics are used to identify the causes of fetal anomalies detected on ultrasound. If ultrasound findings appear to indicate a genetic disorder, sequencing methods offer the opportunity to safely diagnose numerous genetic disorders prenatally with the help of diagnostic puncture and aspiration. Depending on the type of ultrasound abnormality, massive parallel sequencing (MPS) (the terms \"high throughput sequencing\" and \"next generation sequencing\" [NGS] are often used synonymously) can identify up to 50% of the causes of fetal malformations (skeletal abnormalities). Confirmation of a genetic disorder makes it possible to inform and advise pregnant women or parents who are looking for advice about the expected development of their unborn child and provides a science-based assessment of the risk of recurrence. This review article describes the benefits and special features of prenatal diagnostic tests using next generation sequencing and looks ahead at the developments in molecular genetic diagnostic procedures which may be used for the prenatal confirmation of genetic disorders in the future.</p>","PeriodicalId":12481,"journal":{"name":"Geburtshilfe Und Frauenheilkunde","volume":"85 9","pages":"934-940"},"PeriodicalIF":1.9000,"publicationDate":"2025-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12404791/pdf/","citationCount":"0","resultStr":"{\"title\":\"Opportunities and Limitations of Modern High Throughput Sequencing in Invasive Prenatal Diagnostics.\",\"authors\":\"Heinz Gabriel, Markus Stumm\",\"doi\":\"10.1055/a-2567-3396\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Prenatal diagnostics are used to identify the causes of fetal anomalies detected on ultrasound. If ultrasound findings appear to indicate a genetic disorder, sequencing methods offer the opportunity to safely diagnose numerous genetic disorders prenatally with the help of diagnostic puncture and aspiration. Depending on the type of ultrasound abnormality, massive parallel sequencing (MPS) (the terms \\\"high throughput sequencing\\\" and \\\"next generation sequencing\\\" [NGS] are often used synonymously) can identify up to 50% of the causes of fetal malformations (skeletal abnormalities). Confirmation of a genetic disorder makes it possible to inform and advise pregnant women or parents who are looking for advice about the expected development of their unborn child and provides a science-based assessment of the risk of recurrence. This review article describes the benefits and special features of prenatal diagnostic tests using next generation sequencing and looks ahead at the developments in molecular genetic diagnostic procedures which may be used for the prenatal confirmation of genetic disorders in the future.</p>\",\"PeriodicalId\":12481,\"journal\":{\"name\":\"Geburtshilfe Und Frauenheilkunde\",\"volume\":\"85 9\",\"pages\":\"934-940\"},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2025-07-11\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12404791/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Geburtshilfe Und Frauenheilkunde\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2567-3396\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/9/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q2\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Geburtshilfe Und Frauenheilkunde","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2567-3396","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

产前诊断用于确定超声检测胎儿异常的原因。如果超声检查结果显示遗传疾病,测序方法提供了在诊断穿刺和穿刺的帮助下安全地产前诊断许多遗传疾病的机会。根据超声异常的类型,大规模平行测序(MPS)(术语“高通量测序”和“下一代测序”[NGS]通常同义使用)可以识别多达50%的胎儿畸形(骨骼异常)的原因。确认一种遗传性疾病,可以告知孕妇或正在寻求有关未出生婴儿预期发育建议的父母并向他们提供建议,并提供基于科学的复发风险评估。这篇综述文章描述了使用下一代测序的产前诊断测试的好处和特点,并展望了分子遗传诊断程序的发展,这些程序可能在未来用于产前确认遗传疾病。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Opportunities and Limitations of Modern High Throughput Sequencing in Invasive Prenatal Diagnostics.

Opportunities and Limitations of Modern High Throughput Sequencing in Invasive Prenatal Diagnostics.

Opportunities and Limitations of Modern High Throughput Sequencing in Invasive Prenatal Diagnostics.

Prenatal diagnostics are used to identify the causes of fetal anomalies detected on ultrasound. If ultrasound findings appear to indicate a genetic disorder, sequencing methods offer the opportunity to safely diagnose numerous genetic disorders prenatally with the help of diagnostic puncture and aspiration. Depending on the type of ultrasound abnormality, massive parallel sequencing (MPS) (the terms "high throughput sequencing" and "next generation sequencing" [NGS] are often used synonymously) can identify up to 50% of the causes of fetal malformations (skeletal abnormalities). Confirmation of a genetic disorder makes it possible to inform and advise pregnant women or parents who are looking for advice about the expected development of their unborn child and provides a science-based assessment of the risk of recurrence. This review article describes the benefits and special features of prenatal diagnostic tests using next generation sequencing and looks ahead at the developments in molecular genetic diagnostic procedures which may be used for the prenatal confirmation of genetic disorders in the future.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Geburtshilfe Und Frauenheilkunde
Geburtshilfe Und Frauenheilkunde 医学-妇产科学
CiteScore
2.50
自引率
22.20%
发文量
828
审稿时长
6-12 weeks
期刊介绍: Geburtshilfe und Frauenheilkunde (GebFra) addresses the whole field of obstetrics and gynecology and is concerned with research as much as with clinical practice. In its scientific section, it publishes original articles, reviews and case reports in all fields of the discipline, namely gynecological oncology, including oncology of the breast obstetrics and perinatal medicine, reproductive medicine, and urogynecology. GebFra invites the submission of original articles and review articles. In addition, the journal publishes guidelines, statements and recommendations in cooperation with the DGGG, SGGG, OEGGG and the Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF, Association of Scientific Medical Societies, www.awmf.org). Apart from the scientific section, Geburtshilfe und Frauenheilkunde has a news and views section that also includes discussions, book reviews and professional information. Letters to the editors are welcome. If a letter discusses an article that has been published in our journal, the corresponding author of the article will be informed and invited to comment on the letter. The comment will be published along with the letter.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信